Lead Product(s) : LPH-5
Therapeutic Area : Psychiatry/Psychology
Study Phase : Preclinical
Sponsor : Beckley Psytech
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the terms of the agreement Beckley Psytech will jointly fund continuing development of the Lophora pipeline including it's lead candidate LPH-5 and collaborate broadly on R&D.
Product Name : LPH-5
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
November 05, 2022
Lead Product(s) : LPH-5
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Preclinical
Sponsor : Beckley Psytech
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Psilocybine
Therapeutic Area : Psychiatry/Psychology
Study Phase : Preclinical
Sponsor : Clerkenwell Health
Deal Size : Undisclosed
Deal Type : Partnership
Details : Through the partnership, Octarine now has access to services from Clerkenwell Health to expedite its clinical development with biosynthetic psilocybin and expects to be able to fast-track steps leading to human clinical trials.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Undisclosed
August 09, 2021
Lead Product(s) : Psilocybine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Preclinical
Sponsor : Clerkenwell Health
Deal Size : Undisclosed
Deal Type : Partnership